GlassScriptPhysician profile
Jonathan Paul Clarke
NPI 1942641121
$252.13
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.82 · 2020: $38.88 · 2021: $85.34 · 2022: $49.09.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $88.52 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $44.42 | 2019-2022 | |
| Glaxosmithkline, LLC. | $34.06 | 2021-2022 | |
| Vapotherm INC | $20.57 | 2019 | |
| Alkermes, INC. | $17.96 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.68 | 2022 | |
| Abbvie INC. | $16.63 | 2021 | |
| Merck Sharp & Dohme LLC | $13.29 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Clarke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.